• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童非酒精性脂肪性肝病纤维化指数:非酒精性脂肪性肝病患儿肝纤维化的预测指标。

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease.

作者信息

Nobili Valerio, Alisi Anna, Vania Andrea, Tiribelli Claudio, Pietrobattista Andrea, Bedogni Giorgio

机构信息

Department of Hepatogastroenterology and Nutrition, Pediatric Hospital IRCCS Bambino Gesù, Via S, Onofrio 4, 00165 Rome, Italy.

出版信息

BMC Med. 2009 May 1;7:21. doi: 10.1186/1741-7015-7-21.

DOI:10.1186/1741-7015-7-21
PMID:19409076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2684116/
Abstract

BACKGROUND

Liver fibrosis is a stage of non-alcoholic fatty liver disease (NAFLD) which is responsible for liver-related morbidity and mortality in adults. Accordingly, the search for non-invasive markers of liver fibrosis has been the subject of intensive efforts in adults with NAFLD. Here, we developed a simple algorithm for the prediction of liver fibrosis in children with NAFLD followed at a tertiary care center.

METHODS

The study included 136 male and 67 female children with NAFLD aged 3.3 to 18.0 years; 141 (69%) of them had fibrosis at liver biopsy. On the basis of biological plausibility, readily availability and evidence from adult studies, we evaluated the following potential predictors of liver fibrosis at bootstrapped stepwise logistic regression: gender, age, body mass index, waist circumference, alanine transaminase, aspartate transaminase, gamma-glutamyl-transferase, albumin, prothrombin time, glucose, insulin, triglycerides and cholesterol. A final model was developed using bootstrapped logistic regression with bias-correction. We used this model to develop the 'pediatric NAFLD fibrosis index' (PNFI), which varies between 0 and 10.

RESULTS

The final model was based on age, waist circumference and triglycerides and had a area under the receiver operating characteristic curve of 0.85 (95% bootstrapped confidence interval (CI) with bias correction 0.80 to 0.90) for the prediction of liver fibrosis. A PNFI >or= 9 (positive likelihood ratio = 28.6, 95% CI 4.0 to 201.0; positive predictive value = 98.5, 95% CI 91.8 to 100.0) could be used to rule in liver fibrosis without performing liver biopsy.

CONCLUSION

PNFI may help clinicians to predict liver fibrosis in children with NAFLD, but external validation is needed before it can be employed for this purpose.

摘要

背景

肝纤维化是非酒精性脂肪性肝病(NAFLD)的一个阶段,在成人中它是导致肝脏相关发病和死亡的原因。因此,寻找肝纤维化的非侵入性标志物一直是NAFLD成人患者深入研究的课题。在此,我们开发了一种简单算法,用于预测在三级医疗中心随访的NAFLD儿童的肝纤维化情况。

方法

该研究纳入了136名男性和67名女性NAFLD儿童,年龄在3.3至18.0岁之间;其中141名(69%)在肝活检时有纤维化。基于生物学合理性、可得性以及成人研究的证据,我们在自抽样逐步逻辑回归中评估了以下肝纤维化的潜在预测因素:性别、年龄、体重指数、腰围、丙氨酸转氨酶、天冬氨酸转氨酶、γ-谷氨酰转移酶、白蛋白、凝血酶原时间、葡萄糖、胰岛素、甘油三酯和胆固醇。使用带有偏差校正的自抽样逻辑回归建立了最终模型。我们用这个模型开发了“儿童NAFLD纤维化指数”(PNFI),其范围在0到10之间。

结果

最终模型基于年龄、腰围和甘油三酯,在预测肝纤维化方面,受试者工作特征曲线下面积为0.85(95%自抽样偏差校正置信区间(CI)为0.80至0.90)。PNFI≥9(阳性似然比 = 28.6,95% CI为4.0至201.0;阳性预测值 = 98.5,95% CI为91.8至100.0)可用于在不进行肝活检的情况下判定肝纤维化。

结论

PNFI可能有助于临床医生预测NAFLD儿童的肝纤维化,但在用于此目的之前需要进行外部验证。

相似文献

1
The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease.儿童非酒精性脂肪性肝病纤维化指数:非酒精性脂肪性肝病患儿肝纤维化的预测指标。
BMC Med. 2009 May 1;7:21. doi: 10.1186/1741-7015-7-21.
2
Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.联合儿科非酒精性脂肪性肝病纤维化指数和瞬时弹性成像预测儿童脂肪肝的临床显著纤维化。
Liver Int. 2013 Jan;33(1):79-85. doi: 10.1111/liv.12024. Epub 2012 Nov 12.
3
A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis.联合儿科非酒精性脂肪性肝病纤维化指数和增强型肝纤维化检测可识别出纤维化患儿。
Clin Gastroenterol Hepatol. 2011 Feb;9(2):150-5. doi: 10.1016/j.cgh.2010.09.015. Epub 2010 Oct 1.
4
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病的脂肪肝指数与腰围对比
World J Gastroenterol. 2016 Mar 14;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023.
5
Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.腰围与非酒精性脂肪性肝炎患儿的肝纤维化相关。
Gut. 2008 Sep;57(9):1283-7. doi: 10.1136/gut.2007.142919. Epub 2008 Jan 24.
6
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.简单的非侵入性纤维化评分系统可以可靠地排除非酒精性脂肪性肝病患者的晚期纤维化。
Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.
7
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.脂肪肝指数:普通人群肝脂肪变性的简单准确预测指标。
BMC Gastroenterol. 2006 Nov 2;6:33. doi: 10.1186/1471-230X-6-33.
8
Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.分析与疑似小儿非酒精性脂肪性肝病和潜在肝纤维化相关的饮食因素:韩国 2014-2017 年国家健康和营养检查调查。
BMC Pediatr. 2020 Mar 14;20(1):121. doi: 10.1186/s12887-020-02022-y.
9
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者纤维化无创标志物的比较
Clin Gastroenterol Hepatol. 2009 Oct;7(10):1104-12. doi: 10.1016/j.cgh.2009.05.033. Epub 2009 Jun 10.
10
Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.拉丁人群中非酒精性脂肪性肝病无创性纤维化诊断系统的验证研究。
Ann Hepatol. 2013 May-Jun;12(3):416-24.

引用本文的文献

1
Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease.构建基于社区的小儿非酒精性脂肪性肝病初级筛查及基于医院的确诊筛查路径。
World J Gastroenterol. 2025 Jul 28;31(28):108321. doi: 10.3748/wjg.v31.i28.108321.
2
Pathological Evolution and Internal Medicine Management of Nonalcoholic Fatty Liver Disease (NAFLD) in the Era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).代谢功能障碍相关脂肪性肝病(MASLD)时代非酒精性脂肪性肝病(NAFLD)的病理演变与内科管理
Cureus. 2025 Jun 29;17(6):e86963. doi: 10.7759/cureus.86963. eCollection 2025 Jun.
3
Consensus Statement on Metabolic Dysfunction-Associated Steatotic Liver Disease in Children and Adolescents From the Joint TASL-TSPGHAN Expert Committee.TASL-TSPGHAN联合专家委员会关于儿童和青少年代谢功能障碍相关脂肪性肝病的共识声明。
JGH Open. 2025 Jun 12;9(6):e70137. doi: 10.1002/jgh3.70137. eCollection 2025 Jun.
4
High Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents with Severe Obesity.重度肥胖儿童及青少年中代谢相关脂肪性肝病(MAFLD)的高患病率
J Clin Med. 2025 May 20;14(10):3565. doi: 10.3390/jcm14103565.
5
Sex Differences in Body Composition and MASLD in Children With Overweight and Obesity.超重和肥胖儿童身体成分与代谢功能障碍相关脂肪性肝病的性别差异
Acta Paediatr. 2025 Jul;114(7):1709-1719. doi: 10.1111/apa.70026. Epub 2025 Feb 13.
6
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.KASL慢性肝病肝纤维化评估无创检测临床实践指南。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S5-S105. doi: 10.3350/cmh.2024.0506. Epub 2024 Aug 19.
7
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者临床评估与管理的TASL实践指南。
Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023.
8
Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.Fibro-PeN 的研发:一种用于诊断非酒精性脂肪性肝病患儿中-重度肝纤维化的临床预测模型。
Hepatology. 2024 Jun 1;79(6):1381-1392. doi: 10.1097/HEP.0000000000000644. Epub 2023 Oct 23.
9
Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol.儿童和青少年非酒精性脂肪性肝病的临床流行病学。LiverKids:研究方案。
PLoS One. 2023 Oct 13;18(10):e0286586. doi: 10.1371/journal.pone.0286586. eCollection 2023.
10
New predictive models and indices for screening MAFLD in school-aged overweight/obese children.用于筛查学龄期超重/肥胖儿童 MAFLD 的新型预测模型和指标。
Eur J Pediatr. 2023 Nov;182(11):5025-5036. doi: 10.1007/s00431-023-05175-x. Epub 2023 Aug 30.

本文引用的文献

1
Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.腰围与非酒精性脂肪性肝炎患儿的肝纤维化相关。
Gut. 2008 Sep;57(9):1283-7. doi: 10.1136/gut.2007.142919. Epub 2008 Jan 24.
2
Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.儿童非酒精性脂肪性肝炎中的代谢综合征与肝脏组织学
Int J Obes (Lond). 2008 Feb;32(2):381-7. doi: 10.1038/sj.ijo.0803711. Epub 2007 Dec 18.
3
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.非酒精性脂肪性肝病纤维化的非侵入性标志物:验证欧洲肝纤维化检测组合并探索简易标志物
Hepatology. 2008 Feb;47(2):455-60. doi: 10.1002/hep.21984.
4
Incidence and natural course of fatty liver in the general population: the Dionysos study.普通人群中脂肪肝的发病率及自然病程:狄俄尼索斯研究
Hepatology. 2007 Nov;46(5):1387-91. doi: 10.1002/hep.21827.
5
The metabolic syndrome in children and adolescents.儿童和青少年的代谢综合征
Lancet. 2007 Jun 23;369(9579):2059-61. doi: 10.1016/S0140-6736(07)60958-1.
6
Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.肝活检及肝纤维化血清标志物在非酒精性脂肪性肝病中的作用
Clin Liver Dis. 2007 Feb;11(1):25-35, viii. doi: 10.1016/j.cld.2007.02.004.
7
Nonalcoholic fatty liver disease and insulin resistance in youth.青少年非酒精性脂肪性肝病与胰岛素抵抗
Diabetes Care. 2007 Jun;30(6):1663-9. doi: 10.2337/dc07-zb06.
8
Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?儿童非酒精性脂肪性肝病(NAFLD):一个“日益严重”的问题?
J Hepatol. 2007 Jun;46(6):1133-42. doi: 10.1016/j.jhep.2007.03.003. Epub 2007 Mar 26.
9
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.非酒精性脂肪性肝病纤维化评分:一种用于识别非酒精性脂肪性肝病患者肝纤维化的非侵入性系统。
Hepatology. 2007 Apr;45(4):846-54. doi: 10.1002/hep.21496.
10
Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome.儿童代谢风险因素聚集评估:划定儿童代谢综合征的界限
Int J Obes (Lond). 2007 Apr;31(4):591-600. doi: 10.1038/sj.ijo.0803581.